Kala Pharma Grabs $22.5M More For Eye Drugs – Xconomy

Kala Pharma Grabs $22.5M More For Eye Drugs
Xconomy
The so-called “wet” form of age-related macular degeneration, for instance—when abnormal blood vessels grow in the macula and leak behind the eye, leading to distorted vision and potential blindness—is typically treated with injections of bevacizumab …
Kala reels in $22.5M to get its next-gen eye drops into PhIIIFierceBiotech
Kala Pharmaceuticals Announces $22.5 Million Series B FinancingThe Herald | HeraldOnline.com (press release)

all 7 news articles

…read more

Source: Wet Macular Degeneration News From Google News

Leave a Comment